Drug profile · INN
nirogacestat hydrobromide
OGSIVEO
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
nirogacestat hydrobromide (OGSIVEO) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN nirogacestat hydrobromide
Brand OGSIVEO
Route ORAL
Formulation TABLET
Frequently asked questions
What is nirogacestat hydrobromide?
nirogacestat hydrobromide (OGSIVEO) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for nirogacestat hydrobromide?
OGSIVEO is a marketed brand name for nirogacestat hydrobromide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of nirogacestat hydrobromide?
nirogacestat hydrobromide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.